Search clinical trials for: Sirolimus 2%

Total 17193 results

National Cancer Institute (NCI)

Terminated

Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders

Leukemia | Multiple Myeloma | MDS | Non-Hodgkins Lymphoma | Hodgkins Lymphoma

United States
Harbin Medical University

Unknown

Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT (DM-COVER)

Diabetes Mellitus | Coronary Heart Disease

China
Novartis Pharmaceuticals

Completed

A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients

Primary Biliary Cholangitis

United States, Germany, Russian Federation, Canada, United Kingdom, Poland
The University of Texas Health Science Center at...
Abfero Pharmaceuticals, Inc

Suspended

Safety of SP-420 in the Treatment of Transfusional Iron Overload

Iron Overload

United States
German Institute of Human Nutrition
German Center for Diabetes Research; Firma Rettenmeier & Söhne (Company)

Unknown

Diabetes Nutrition Algorithms - Sugars: Galactose- and Fiber-induced Metabolic Improvement in the Dietetic Treatment of Type 2 Diabetes (DiNA-S DiNA-F)

Type 2 Diabetes

Germany
University of Minnesota
Melanoma Research Alliance

Withdrawn

Pilot Study of Intervention to Reduce Sunburns in Melanoma Survivors

Melanoma (Skin)
Institut für Pneumologie Hagen Ambrock eV
Weinmann Geräte für Medizin GmbH + Co. KG

Completed

The Effects of Airtrapping on Sleep and Breathing in Non Invasive Ventilation (NIV) in COPD

COPD | Hypercapnic Respiratory Failure

Germany
Morehouse School of Medicine
National Cancer Institute (NCI)

Unknown

Educational Program to Increase Colorectal Cancer Screening: a Cluster Trial (EPICS)

Colorectal Cancer

United States
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Recruiting

Sirolimus DEB in Coronary Bifurcation Lesions

Coronary Bifurcation Lesions

China
Biotyx Medical (Shenzhen) Co., Ltd.

Active, not recruiting

A Clinical Investigation to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease (IRONMAN-II)

Coronary Artery Disease

China
Seung-Jung Park
Cordis Corporation; CardioVascular Research Foundation, Korea

Terminated

Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients (ZEST-AMI)

Myocardial Infarction

Korea, Republic of
King Hussein Cancer Center

Withdrawn

Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients (COVID19-HOPE)

COVID-19 Patients

Jordan
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Optimal Stenting Strategy For True Bifurcation Lesions (PERFECT)

Coronary Artery Disease

Korea, Republic of
Santen Inc.
MacuSight, Inc.

Terminated

Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration (EMERALD)

Age-Related Macular Degeneration | Choroidal Neovascularization

United States
Catharina Ziekenhuis Eindhoven
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Compusense... and other collaborators

Completed

Comparison of Drug Eluting and Bare Metal Stents With or Without Abciximab in ST Elevation Myocardial Infarction (DEBATER)

Acute Myocardial Infarction

Netherlands
University of Copenhagen
Nordea-fonden

Completed

The Effects of Sea Buckthorn and Strawberry on Postprandial Glycaemia, Insulinemia and Appetite (OPUS-WP3C)

Glucose Intolerance | Insulin Sensitivity

Denmark
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Enasidenib as Maintenance Therapy in Treating Patients With Acute Myeloid Leukemia With IDH2 Mutation After Donor Stem Cell Transplant

Acute Myeloid Leukemia

United States
GID BIO, Inc.

Not yet recruiting

Adipose-derived SVF for Treatment of Erectile Dysfunction (ED)

Erectile Dysfunction

United States
Meshalkin Research Institute of Pathology of Circulation

Unknown

SARS-CoV-2 Disguise Study (Disguise)

Sars-CoV2

Russian Federation
Institute of Medical Biology, Chinese Academy of...
Guangxi Center for Disease Control and Prevention

Completed

Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV

Poliomyelitis

China
Cell Energy Life Sciences Group Co. LTD
Beijing 302 Hospital

Recruiting

Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases

Lung Injury

China
BTL Industries Ltd.

Completed

Radiofrequency and Ultrasound for Improvement of Skin Laxity and Wrinkles: Efficacy and Safety Evaluation

Skin Laxity

United States
Beth Israel Medical Center

Completed

Study of Mattress Type in Fibromyalgia

Fibromyalgia

United States
Roswell Park Cancer Institute

Withdrawn

Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer

Esophageal Neoplasm
Ono Pharmaceutical Co. Ltd

Completed

Phase 1 Study of ONO-7475 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

Japan
Duke University
National Institute of Mental Health (NIMH)

Completed

CAMPUS - Feasibility Sub-Study (CAMPUS-Feas)

Suicide

United States
Kythera Biopharmaceuticals

Completed

Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

Healthy | Submental Fat

United States, Canada, Australia, United Kingdom
Aarhus University Hospital Skejby
Medtronic Cardiovascular; Biosensors International

Completed

SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity® (SO VI)

Coronary Artery Disease | Angina Pectoris

Denmark
University Ghent

Completed

An Explorative RVA of the Motor Development of Children With DCD <2y (RVA_DCD)

Autism Spectrum Disorder | Developmental Coordination Disorder

Belgium, Canada
Galderma R&D

Completed

Performance of Different Application Regimens of ACTINICA® on Protection From UVR-induced Erythema After One Day of Sun Exposure in Fair-skinned Healthy Subjects.

Healthy Subjects, Male or Female, of 18-60 Years Old, With Phototype I, II or III, Not Pre-treated/Pre-protected Skin

France
University Hospital Heidelberg
German Cancer Research Center; National Center for Tumor Diseases, Heidelberg; German Cancer Aid

Completed

NCT Neuro Master Match - N²M² (NOA-20) (N²M²)

Glioblastoma, Adult

Germany
M.D. Anderson Cancer Center

Not yet recruiting

Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder

Familial Platelet Disorder | Hematopoietic

United States
Peking Union Medical College Hospital

Recruiting

Sirolimus in the Treatment of Refractory/Relapsed wAIHA

Warm Autoimmune Hemolytic Anemia

China
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Sirolimus in Cutaneous Sarcoidosis (SIRIUS)

Sarcoidosis | Cutaneous Sarcoidosis
Medical University of South Carolina

Recruiting

Weekly Sirolimus Therapy

Lymphatic Malformation | Venous Malformation

United States
National Eye Institute (NEI)

Completed

Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti

Anterior Uveitis

United States
Seoul St. Mary's Hospital

Unknown

Study to Evaluate Safety and Immunologic Biomarker of Rapamune in Patients With Stable Renal Transplant Recipient

Acute Rejection of Renal Transplant

Korea, Republic of
Vanderbilt University
Genzyme, a Sanofi Company

Completed

Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation

Kidney Transplantation

United States
University of Missouri-Columbia

Recruiting

Short Term Sirolimus Treatment and MRI of the Brain

Genetic Predisposition to Disease | Healthy Volunteers

United States
University of Texas Southwestern Medical Center

Not yet recruiting

The Role of Sirolimus in Preventing Functional Decline in Older Adults

Aging
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy

Severe Aplastic Anemia

United States
National Institute of Diabetes and Digestive and...

Completed

Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy

Membranous Glomerulonephritis | Lupus Membranous Nepropathy

United States
University Hospital, Rouen

Completed

Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation (EPARGNE)

Kidney Transplantation

France
Mayo Clinic
Wyeth is now a wholly owned subsidiary of Pfizer; Genzyme, a Sanofi Company; Raymond...

Completed

Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no Steroids

Kidney Diseases

United States
National Institute of Diabetes and Digestive and...

Completed

Sirolimus for Focal Segmental Glomerulosclerosis

Focal Glomerulosclerosis

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients

Graft Rejection | Kidney Failure | Kidney Transplant
Universidad de Almeria
Leiden University Medical Center; ETH Zurich (Switzerland)

Not yet recruiting

Deciphering a Novel and Unique Brown Adipose Tissue Depot in Women (DEBATE)

Cardiometabolic Diseases

Spain
Translumina GmbH

Terminated

Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis

Coronary Disease

Germany, Israel, Austria
Abbott Nutrition

Completed

Tolerance of Healthy Infants Fed Infant Formulas

Gastrointestinal Tolerance

United States
University of Michigan
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Sleep-disordered Breathing in Infants With Myelomeningocele

Sleep-disordered Breathing | Myelomeningocele

United States

Search clinical trials for: Sirolimus 2%

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations